Pediatric Asthma Management in China: Current and Future Challenges
Pediatric Asthma Management in China: Current and Future Challenges
复制标题
DOI：
10.1007/s40272-017-0276-7
复制
发表时间：
2018-04-01
期刊：
影响因子：
3.7
通讯作者：
Hong, Jianguo
中科院分区：
文献类型：
--
作者：
Zhou, Xiaojian;Hong, Jianguo
本报告的目的是回顾中国哮喘诊断和治疗的现状，并探讨实现早期诊断和治疗的挑战。中国儿童哮喘的患病率在过去几十年中有所增加，2013年公布的数据显示0-14岁儿童的患病率为3.0%。虽然发病率有所上升，但急性哮喘发作的儿童比例从2000年的86%下降到2010年的77%，哮喘发作的住院频率从54.0%下降到47%。这些下降归因于积极推广全球哮喘防治倡议（GINA）方案和更新的中国儿童哮喘防治指南。2000年至2010年期间，吸入性皮质类固醇的使用增加，全身性皮质类固醇的使用减少。尽管取得了这些进展，但仍有一些问题有待解决。父母缺乏哮喘的基本知识，害怕使用皮质类固醇。缺乏关于6岁以下儿童哮喘诊断的医生教育。患者需要接受吸入性皮质类固醇管理和环境触发控制方面的培训。中国国家儿童哮喘指南已经更新，但实施仍然是一个真实的挑战。
The purpose of this report was to review the state of asthma diagnosis and treatment in China and to examine challenges in achieving earlier diagnosis and treatment. The prevalence of asthma in children in China has increased over past decades, and data published in 2013 indicated a prevalence of 3.0% in children aged 0-14 years. Although this prevalence has increased, the percentage of children with acute asthma attacks decreased from 86% in 2000 to 77% in 2010, and the frequency of hospitalizations for asthma attacks decreased from 54.0 to 47%. These decreases are attributed to aggressive promotion of the Global Initiative for Asthma (GINA) protocol and updated Chinese guidelines for the prevention and treatment of asthma in children. The use of inhaled corticosteroids increased and that of systemic corticosteroids decreased between 2000 and 2010. Despite these advances, a number of issues remain to be addressed. Parents lack basic knowledge of asthma and fear the use of corticosteroids. Physician education regarding the diagnosis of asthma in children aged < 6 years is lacking. Patients require training in the administration of inhaled corticosteroids and control of environmental triggers. The Chinese national guidelines for childhood asthma have been updated, but implementation remains a real challenge.